|  Help  |  About  |  Contact Us

Search our database by keyword

- or -

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 1 to 100 out of 1882 for Dmd

Category restricted to Publication (x)

<< First    < Previous  |  Next >    Last >>
0.075s

Categories

Category: Publication
Type Details Score
Publication
First Author: Wan H
Year: 2016
Journal: Mol Microbiol
Title: Structural insights into the inhibition mechanism of bacterial toxin LsoA by bacteriophage antitoxin Dmd.
Volume: 101
Issue: 5
Pages: 757-69
Publication  
First Author: Alexander MS
Year: 2011
Journal: Skelet Muscle
Title: Regulation of DMD pathology by an ankyrin-encoded miRNA.
Volume: 1
Pages: 27
Publication  
First Author: Lin Y
Year: 2023
Journal: Biomedicines
Title: Characterization of the Ang/Tie2 Signaling Pathway in the Diaphragm Muscle of DMD Mice.
Volume: 11
Issue: 8
Publication
First Author: Rodino-Klapac LR
Year: 2013
Journal: Hum Mol Genet
Title: Micro-dystrophin and follistatin co-delivery restores muscle function in aged DMD model.
Volume: 22
Issue: 24
Pages: 4929-37
Publication
First Author: Benchaouir R
Year: 2007
Journal: Cell Stem Cell
Title: Restoration of human dystrophin following transplantation of exon-skipping-engineered DMD patient stem cells into dystrophic mice.
Volume: 1
Issue: 6
Pages: 646-57
Publication
First Author: Liu G
Year: 2024
Journal: Hum Mol Genet
Title: Comparison of pharmaceutical properties and biological activities of prednisolone, deflazacort, and vamorolone in DMD disease models.
Volume: 33
Issue: 3
Pages: 211-223
Publication  
First Author: Arreguin AJ
Year: 2024
Journal: Dis Model Mech
Title: Dmd mdx mice have defective oligodendrogenesis, delayed myelin compaction and persistent hypomyelination.
Volume: 17
Issue: 4
Publication
First Author: Sarig R
Year: 1999
Journal: Hum Mol Genet
Title: Targeted inactivation of Dp71, the major non-muscle product of the DMD gene: differential activity of the Dp71 promoter during development.
Volume: 8
Issue: 1
Pages: 1-10
Publication
First Author: 't Hoen PA
Year: 2008
Journal: J Biol Chem
Title: Generation and characterization of transgenic mice with the full-length human DMD gene.
Volume: 283
Issue: 9
Pages: 5899-907
Publication
First Author: Mamsa H
Year: 2022
Journal: Hum Mol Genet
Title: Sarcospan increases laminin-binding capacity of α-dystroglycan to ameliorate DMD independent of Galgt2.
Volume: 31
Issue: 5
Pages: 718-732
Publication  
First Author: Petkova MV
Year: 2016
Journal: Skelet Muscle
Title: Characterization of a Dmd (EGFP) reporter mouse as a tool to investigate dystrophin expression.
Volume: 6
Pages: 25
Publication  
First Author: Roy A
Year: 2023
Journal: JCI Insight
Title: Targeted regulation of TAK1 counteracts dystrophinopathy in a DMD mouse model.
Volume: 8
Issue: 10
Publication
First Author: Wein N
Year: 2014
Journal: Nat Med
Title: Translation from a DMD exon 5 IRES results in a functional dystrophin isoform that attenuates dystrophinopathy in humans and mice.
Volume: 20
Issue: 9
Pages: 992-1000
Publication  
First Author: Mázala DA
Year: 2020
Journal: JCI Insight
Title: TGF-β-driven muscle degeneration and failed regeneration underlie disease onset in a DMD mouse model.
Volume: 5
Issue: 6
Publication
First Author: Gutpell KM
Year: 2017
Journal: PLoS One
Title: ANG1 treatment reduces muscle pathology and prevents a decline in perfusion in DMD mice.
Volume: 12
Issue: 3
Pages: e0174315
Publication
First Author: Koenig M
Year: 1987
Journal: Cell
Title: Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals.
Volume: 50
Issue: 3
Pages: 509-17
Publication  
First Author: Vitiello L
Year: 2018
Journal: Front Physiol
Title: Drug Repurposing for Duchenne Muscular Dystrophy: The Monoamine Oxidase B Inhibitor Safinamide Ameliorates the Pathological Phenotype in mdx Mice and in Myogenic Cultures From DMD Patients.
Volume: 9
Pages: 1087
Publication
First Author: Amirouche A
Year: 2013
Journal: Hum Mol Genet
Title: Activation of p38 signaling increases utrophin A expression in skeletal muscle via the RNA-binding protein KSRP and inhibition of AU-rich element-mediated mRNA decay: implications for novel DMD therapeutics.
Volume: 22
Issue: 15
Pages: 3093-111
Publication
First Author: García-Rodríguez R
Year: 2020
Journal: Proc Natl Acad Sci U S A
Title: Premature termination codons in the DMD gene cause reduced local mRNA synthesis.
Volume: 117
Issue: 28
Pages: 16456-16464
Publication  
First Author: Wong TWY
Year: 2020
Journal: Dis Model Mech
Title: A novel mouse model of Duchenne muscular dystrophy carrying a multi-exonic Dmd deletion exhibits progressive muscular dystrophy and early-onset cardiomyopathy.
Volume: 13
Issue: 9
Publication  
First Author: Egorova TV
Year: 2019
Journal: Dis Model Mech
Title: CRISPR/Cas9-generated mouse model of Duchenne muscular dystrophy recapitulating a newly identified large 430 kb deletion in the human DMD gene.
Volume: 12
Issue: 4
Publication
First Author: Dalloz C
Year: 2003
Journal: Hum Mol Genet
Title: Targeted inactivation of dystrophin gene product Dp71: phenotypic impact in mouse retina.
Volume: 12
Issue: 13
Pages: 1543-54
Publication
First Author: Chaussenot R
Year: 2019
Journal: Mol Neurobiol
Title: Dp71-Dystrophin Deficiency Alters Prefrontal Cortex Excitation-Inhibition Balance and Executive Functions.
Volume: 56
Issue: 4
Pages: 2670-2684
Publication  
First Author: Helleringer R
Year: 2018
Journal: Dis Model Mech
Title: Cerebellar synapse properties and cerebellum-dependent motor and non-motor performance in Dp71-null mice.
Volume: 11
Issue: 7
Publication
First Author: Hiramuki Y
Year: 2025
Journal: Sci Rep
Title: Titin fragment is a sensitive biomarker in Duchenne muscular dystrophy model mice carrying full-length human dystrophin gene on human artificial chromosome.
Volume: 15
Issue: 1
Pages: 1778
Publication  
First Author: Fort PE
Year: 2014
Journal: Mol Vis
Title: Lack of dystrophin protein Dp71 results in progressive cataract formation due to loss of fiber cell organization.
Volume: 20
Pages: 1480-90
Publication
First Author: Cox GA
Year: 1993
Journal: Nature
Title: Overexpression of dystrophin in transgenic mdx mice eliminates dystrophic symptoms without toxicity.
Volume: 364
Issue: 6439
Pages: 725-9
Publication
First Author: Takatoh J
Year: 2008
Journal: Exp Neurol
Title: Loss of short dystrophin isoform Dp71 in olfactory ensheathing cells causes vomeronasal nerve defasciculation in mouse olfactory system.
Volume: 213
Issue: 1
Pages: 36-47
Publication  
First Author: Lim KRQ
Year: 2021
Journal: Int J Mol Sci
Title: Natural History of a Mouse Model Overexpressing the Dp71 Dystrophin Isoform.
Volume: 22
Issue: 23
Publication
First Author: Young CS
Year: 2017
Journal: J Neuromuscul Dis
Title: Creation of a Novel Humanized Dystrophic Mouse Model of Duchenne Muscular Dystrophy and Application of a CRISPR/Cas9 Gene Editing Therapy.
Volume: 4
Issue: 2
Pages: 139-145
Publication
First Author: Daoud F
Year: 2008
Journal: PLoS One
Title: Role of mental retardation-associated dystrophin-gene product Dp71 in excitatory synapse organization, synaptic plasticity and behavioral functions.
Volume: 4
Issue: 8
Pages: e6574
Publication
First Author: Belmaati Cherkaoui M
Year: 2021
Journal: Glia
Title: Dp71 contribution to the molecular scaffold anchoring aquaporine-4 channels in brain macroglial cells.
Volume: 69
Issue: 4
Pages: 954-970
Publication
First Author: Fort PE
Year: 2008
Journal: Glia
Title: Kir4.1 and AQP4 associate with Dp71- and utrophin-DAPs complexes in specific and defined microdomains of Müller retinal glial cell membrane.
Volume: 56
Issue: 6
Pages: 597-610
Publication
First Author: Giocanti-Auregan A
Year: 2016
Journal: Glia
Title: Altered astrocyte morphology and vascular development in dystrophin-Dp71-null mice.
Volume: 64
Issue: 5
Pages: 716-29
Publication
First Author: Vacca O
Year: 2014
Journal: Glia
Title: AAV-mediated gene delivery in Dp71-null mouse model with compromised barriers.
Volume: 62
Issue: 3
Pages: 468-76
Publication
First Author: El Mathari B
Year: 2015
Journal: Hum Mol Genet
Title: Dystrophin Dp71 gene deletion induces retinal vascular inflammation and capillary degeneration.
Volume: 24
Issue: 14
Pages: 3939-47
Publication
First Author: Vacca O
Year: 2016
Journal: Hum Mol Genet
Title: AAV-mediated gene therapy in Dystrophin-Dp71 deficient mouse leads to blood-retinal barrier restoration and oedema reabsorption.
Volume: 25
Issue: 14
Pages: 3070-3079
Publication
First Author: Benabdesselam R
Year: 2019
Journal: Acta Histochem
Title: Effect of Dp71 deficiency on the oxytocin hypothalamic axis in osmoregulation function in mice.
Volume: 121
Issue: 3
Pages: 268-276
Publication
First Author: Barboni MTS
Year: 2020
Journal: Invest Ophthalmol Vis Sci
Title: Rescue of Defective Electroretinographic Responses in Dp71-Null Mice With AAV-Mediated Reexpression of Dp71.
Volume: 61
Issue: 2
Pages: 11
Publication  
First Author: Ortiz G
Year: 2019
Journal: Mol Vis
Title: Evidence of the involvement of dystrophin Dp71 in corneal angiogenesis.
Volume: 25
Pages: 714-721
Publication
First Author: Hiramuki Y
Year: 2023
Journal: Sci Rep
Title: Full-length human dystrophin on human artificial chromosome compensates for mouse dystrophin deficiency in a Duchenne muscular dystrophy mouse model.
Volume: 13
Issue: 1
Pages: 4360
Publication
First Author: Kudoh H
Year: 2005
Journal: Biochem Biophys Res Commun
Title: A new model mouse for Duchenne muscular dystrophy produced by 2.4 Mb deletion of dystrophin gene using Cre-loxP recombination system.
Volume: 328
Issue: 2
Pages: 507-16
Publication
First Author: Avale ME
Year: 2011
Journal: FASEB J
Title: Prefrontal nicotinic receptors control novel social interaction between mice.
Volume: 25
Issue: 7
Pages: 2145-55
Publication
First Author: Sene A
Year: 2009
Journal: PLoS One
Title: Functional implication of Dp71 in osmoregulation and vascular permeability of the retina.
Volume: 4
Issue: 10
Pages: e7329
Publication
First Author: Marchal GA
Year: 2021
Journal: Sci Rep
Title: Low human dystrophin levels prevent cardiac electrophysiological and structural remodelling in a Duchenne mouse model.
Volume: 11
Issue: 1
Pages: 9779
Publication
First Author: Veltrop M
Year: 2018
Journal: PLoS One
Title: A dystrophic Duchenne mouse model for testing human antisense oligonucleotides.
Volume: 13
Issue: 2
Pages: e0193289
Publication  
First Author: Nishimura D
Year: 2015
Journal: Mech Dev
Title: Roles of ADAM8 in elimination of injured muscle fibers prior to skeletal muscle regeneration.
Volume: 135
Pages: 58-67
Publication
First Author: Yavas A
Year: 2020
Journal: PLoS One
Title: Detailed genetic and functional analysis of the hDMDdel52/mdx mouse model.
Volume: 15
Issue: 12
Pages: e0244215
Publication
First Author: Masubuchi N
Year: 2013
Journal: Exp Anim
Title: Subcellular localization of dystrophin isoforms in cardiomyocytes and phenotypic analysis of dystrophin-deficient mice reveal cardiac myopathy is predominantly caused by a deficiency in full-length dystrophin.
Volume: 62
Issue: 3
Pages: 211-7
Publication
First Author: Miranda R
Year: 2011
Journal: Neurobiol Dis
Title: Altered presynaptic ultrastructure in excitatory hippocampal synapses of mice lacking dystrophins Dp427 or Dp71.
Volume: 43
Issue: 1
Pages: 134-41
Publication
First Author: Wieneke S
Year: 2003
Journal: J Appl Physiol (1985)
Title: Acute pathophysiological effects of muscle-expressed Dp71 transgene on normal and dystrophic mouse muscle.
Volume: 95
Issue: 5
Pages: 1861-6
Publication
First Author: Chamberlain JS
Year: 2010
Journal: Cell
Title: Duchenne muscular dystrophy models show their age.
Volume: 143
Issue: 7
Pages: 1040-2
Publication
First Author: Hanft LM
Year: 2006
Journal: Proc Natl Acad Sci U S A
Title: Cytoplasmic gamma-actin contributes to a compensatory remodeling response in dystrophin-deficient muscle.
Volume: 103
Issue: 14
Pages: 5385-90
Publication
First Author: Nicchia GP
Year: 2008
Journal: Glia
Title: Dystrophin-dependent and -independent AQP4 pools are expressed in the mouse brain.
Volume: 56
Issue: 8
Pages: 869-76
Publication
First Author: Hoffman EP
Year: 1987
Journal: Science
Title: Conservation of the Duchenne muscular dystrophy gene in mice and humans.
Volume: 238
Issue: 4825
Pages: 347-50
Publication
First Author: Deconinck N
Year: 1997
Journal: Nat Med
Title: Expression of truncated utrophin leads to major functional improvements in dystrophin-deficient muscles of mice.
Volume: 3
Issue: 11
Pages: 1216-21
Publication
First Author: Cacchiarelli D
Year: 2011
Journal: EMBO Rep
Title: miR-31 modulates dystrophin expression: new implications for Duchenne muscular dystrophy therapy.
Volume: 12
Issue: 2
Pages: 136-41
Publication
First Author: Louboutin JP
Year: 1993
Journal: Neuromuscul Disord
Title: Morphometric analysis of mdx diaphragm muscle fibres. Comparison with hindlimb muscles.
Volume: 3
Issue: 5-6
Pages: 463-9
Publication
First Author: Wakeford S
Year: 1991
Journal: Muscle Nerve
Title: X-irradiation improves mdx mouse muscle as a model of myofiber loss in DMD.
Volume: 14
Issue: 1
Pages: 42-50
Publication  
First Author: Rogers RG
Year: 2019
Journal: JCI Insight
Title: Disease-modifying bioactivity of intravenous cardiosphere-derived cells and exosomes in mdx mice.
Volume: 4
Issue: 7
Publication
First Author: Sacco A
Year: 2010
Journal: Cell
Title: Short telomeres and stem cell exhaustion model Duchenne muscular dystrophy in mdx/mTR mice.
Volume: 143
Issue: 7
Pages: 1059-71
Publication
First Author: Tinsley JM
Year: 1996
Journal: Nature
Title: Amelioration of the dystrophic phenotype of mdx mice using a truncated utrophin transgene.
Volume: 384
Issue: 6607
Pages: 349-53
Publication
First Author: Di Certo MG
Year: 2010
Journal: Hum Mol Genet
Title: The artificial gene Jazz, a transcriptional regulator of utrophin, corrects the dystrophic pathology in mdx mice.
Volume: 19
Issue: 5
Pages: 752-60
Publication
First Author: Roberts TC
Year: 2015
Journal: Hum Mol Genet
Title: Multi-level omics analysis in a murine model of dystrophin loss and therapeutic restoration.
Volume: 24
Issue: 23
Pages: 6756-68
Publication
First Author: Bishop DP
Year: 2021
Journal: Sci Rep
Title: Quantitative immuno-mass spectrometry imaging of skeletal muscle dystrophin.
Volume: 11
Issue: 1
Pages: 1128
Publication
First Author: Zhang Y
Year: 2017
Journal: Sci Adv
Title: CRISPR-Cpf1 correction of muscular dystrophy mutations in human cardiomyocytes and mice.
Volume: 3
Issue: 4
Pages: e1602814
Publication
First Author: Long C
Year: 2014
Journal: Science
Title: Prevention of muscular dystrophy in mice by CRISPR/Cas9-mediated editing of germline DNA.
Volume: 345
Issue: 6201
Pages: 1184-1188
Publication
First Author: Farini A
Year: 2019
Journal: Am J Pathol
Title: Fibrosis Rescue Improves Cardiac Function in Dystrophin-Deficient Mice and Duchenne Patient-Specific Cardiomyocytes by Immunoproteasome Modulation.
Volume: 189
Issue: 2
Pages: 339-353
Publication
First Author: Pastoret C
Year: 1995
Journal: J Neurol Sci
Title: mdx mice show progressive weakness and muscle deterioration with age.
Volume: 129
Issue: 2
Pages: 97-105
Publication
First Author: Minciacchi D
Year: 2010
Journal: Neuroscience
Title: Alterations of the cortico-cortical network in sensori-motor areas of dystrophin deficient mice.
Volume: 166
Issue: 4
Pages: 1129-39
Publication
First Author: Tracey I
Year: 1996
Journal: J Neurol Sci
Title: An in vivo and in vitro H-magnetic resonance spectroscopy study of mdx mouse brain: abnormal development or neural necrosis?
Volume: 141
Issue: 1-2
Pages: 13-8
Publication  
First Author: Farini A
Year: 2020
Journal: Front Physiol
Title: PTX3 Predicts Myocardial Damage and Fibrosis in Duchenne Muscular Dystrophy.
Volume: 11
Pages: 403
Publication
First Author: Heezen LGM
Year: 2023
Journal: Nat Commun
Title: Spatial transcriptomics reveal markers of histopathological changes in Duchenne muscular dystrophy mouse models.
Volume: 14
Issue: 1
Pages: 4909
Publication
First Author: Tkatchenko AV
Year: 2000
Journal: Biochim Biophys Acta
Title: Large-scale analysis of differential gene expression in the hindlimb muscles and diaphragm of mdx mouse.
Volume: 1500
Issue: 1
Pages: 17-30
Publication
First Author: Stec MJ
Year: 2023
Journal: Proc Natl Acad Sci U S A
Title: A cellular and molecular spatial atlas of dystrophic muscle.
Volume: 120
Issue: 29
Pages: e2221249120
Publication
First Author: Verhaart IEC
Year: 2019
Journal: PLoS One
Title: A modified diet does not ameliorate muscle pathology in a mouse model for Duchenne muscular dystrophy.
Volume: 14
Issue: 4
Pages: e0215335
Publication
First Author: Karpati G
Year: 1990
Journal: J Neuropathol Exp Neurol
Title: Age-related conversion of dystrophin-negative to -positive fiber segments of skeletal but not cardiac muscle fibers in heterozygote mdx mice.
Volume: 49
Issue: 2
Pages: 96-105
Publication
First Author: Brazeau GA
Year: 1992
Journal: Res Commun Chem Pathol Pharmacol
Title: Serum and organ indices of the mdx dystrophic mouse.
Volume: 77
Issue: 2
Pages: 179-89
Publication
First Author: Laurila PP
Year: 2022
Journal: Sci Adv
Title: Inhibition of sphingolipid de novo synthesis counteracts muscular dystrophy.
Volume: 8
Issue: 4
Pages: eabh4423
Publication
First Author: Su X
Year: 2018
Journal: J Cardiovasc Transl Res
Title: Exosome-Derived Dystrophin from Allograft Myogenic Progenitors Improves Cardiac Function in Duchenne Muscular Dystrophic Mice.
Volume: 11
Issue: 5
Pages: 412-419
Publication
First Author: Phelps SF
Year: 1995
Journal: Hum Mol Genet
Title: Expression of full-length and truncated dystrophin mini-genes in transgenic mdx mice.
Volume: 4
Issue: 8
Pages: 1251-8
Publication
First Author: Nelson CE
Year: 2016
Journal: Science
Title: In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy.
Volume: 351
Issue: 6271
Pages: 403-7
Publication
First Author: Tabebordbar M
Year: 2016
Journal: Science
Title: In vivo gene editing in dystrophic mouse muscle and muscle stem cells.
Volume: 351
Issue: 6271
Pages: 407-411
Publication
First Author: Farini A
Year: 2023
Journal: EMBO Mol Med
Title: Microbiota dysbiosis influences immune system and muscle pathophysiology of dystrophin-deficient mice.
Volume: 15
Issue: 3
Pages: e16244
Publication
First Author: Long C
Year: 2016
Journal: Science
Title: Postnatal genome editing partially restores dystrophin expression in a mouse model of muscular dystrophy.
Volume: 351
Issue: 6271
Pages: 400-3
Publication
First Author: Leng Y
Year: 2012
Journal: Neurosci Lett
Title: A comparative study of bone marrow mesenchymal stem cell functionality in C57BL and mdx mice.
Volume: 523
Issue: 2
Pages: 139-44
Publication  
First Author: Timpani CA
Year: 2023
Journal: JCI Insight
Title: Dimethyl fumarate modulates the dystrophic disease program following short-term treatment.
Volume: 8
Issue: 21
Publication
First Author: Dhindsa JS
Year: 2020
Journal: Sci Rep
Title: Motor axonopathies in a mouse model of Duchenne muscular dystrophy.
Volume: 10
Issue: 1
Pages: 8967
Publication
First Author: Vaillend C
Year: 1995
Journal: Behav Genet
Title: Influence of dystrophin-gene mutation on mdx mouse behavior. I. Retention deficits at long delays in spontaneous alternation and bar-pressing tasks.
Volume: 25
Issue: 6
Pages: 569-79
Publication  
First Author: Fuenzalida M
Year: 2016
Journal: Neurobiol Dis
Title: Wnt signaling pathway improves central inhibitory synaptic transmission in a mouse model of Duchenne muscular dystrophy.
Volume: 86
Pages: 109-20
Publication
First Author: Fisher R
Year: 2001
Journal: Neuromuscul Disord
Title: Non-toxic ubiquitous over-expression of utrophin in the mdx mouse.
Volume: 11
Issue: 8
Pages: 713-21
Publication
First Author: Malecova B
Year: 2018
Journal: Nat Commun
Title: Dynamics of cellular states of fibro-adipogenic progenitors during myogenesis and muscular dystrophy.
Volume: 9
Issue: 1
Pages: 3670
Publication
First Author: Dalloz C
Year: 2001
Journal: Mol Cell Neurosci
Title: Differential distribution of the members of the dystrophin glycoprotein complex in mouse retina: effect of the mdx(3Cv) mutation.
Volume: 17
Issue: 5
Pages: 908-20
Publication  
First Author: Bengtsson NE
Year: 2017
Journal: Nat Commun
Title: Muscle-specific CRISPR/Cas9 dystrophin gene editing ameliorates pathophysiology in a mouse model for Duchenne muscular dystrophy.
Volume: 8
Pages: 14454
Publication  
First Author: Rau F
Year: 2015
Journal: Nat Commun
Title: Abnormal splicing switch of DMD's penultimate exon compromises muscle fibre maintenance in myotonic dystrophy.
Volume: 6
Pages: 7205
Publication
First Author: Wang X
Year: 2023
Journal: iScience
Title: Diverse effector and regulatory functions of fibro/adipogenic progenitors during skeletal muscle fibrosis in muscular dystrophy.
Volume: 26
Issue: 1
Pages: 105775
Publication
First Author: Araki E
Year: 1997
Journal: Biochem Biophys Res Commun
Title: Targeted disruption of exon 52 in the mouse dystrophin gene induced muscle degeneration similar to that observed in Duchenne muscular dystrophy.
Volume: 238
Issue: 2
Pages: 492-7
Publication
First Author: Shibuya S
Year: 2001
Journal: Pathol Res Pract
Title: Muscle plasma membrane changes in dystrophin gene exon 52 knockout mouse.
Volume: 197
Issue: 6
Pages: 441-7
Publication
First Author: Amoasii L
Year: 2019
Journal: Nat Commun
Title: In vivo non-invasive monitoring of dystrophin correction in a new Duchenne muscular dystrophy reporter mouse.
Volume: 10
Issue: 1
Pages: 4537
Publication
First Author: Min YL
Year: 2019
Journal: Sci Adv
Title: CRISPR-Cas9 corrects Duchenne muscular dystrophy exon 44 deletion mutations in mice and human cells.
Volume: 5
Issue: 3
Pages: eaav4324